SYLVAMO CORP. DL 1,00 Aktie

Sylvamo reported adjusted EPS of $0.03 for Q2 on revenue of $806 million, significantly missing Wall Street estimates. Despite the earnings miss, adjusted EBITDA doubled sequentially to $60 million and North America margins rose to 15%. Management called 2026 a transition year but expects a strong increase in EBITDA and free cash flow in the second half, as well as a price and mix benefit of $75–85 million. Investors reacted positively, pushing the stock up more than 9% in premarket trading. » More on de.investing.com

Sylvamo reported adjusted EBITDA of $29m (margin 4%) for Q1 2026, after $125m (14%) in the prior quarter, a decline of 77%. Loss per share was $0.08, better than expected; revenue of $755m beat forecasts but fell versus the prior quarter. Volume declines, higher operating costs and increased material and transportation costs weighed on results; Europe posted a negative EBITDA. Management refinanced maturities, launched a lean transformation and plans investments to improve margins, but confirmed guidance for 2026. » More on de.investing.com

Sylvamo shares fell to a 52-week low of $37.50 and are down about 42.5% year-to-date. The stock trades at a P/E ratio of around 13; InvestingPro rates Sylvamo as significantly undervalued and points to an oversold RSI. Operationally the company remains profitable (TTM EPS $3.24) and in Q4 2025 delivered adjusted EPS of $1.08 and revenue of $890 million, beating analysts’ expectations. » More on de.investing.com